These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28642387)

  • 1. Texas signals support for unproven stem cell therapies.
    Servick K
    Science; 2017 Jun; 356(6344):1219. PubMed ID: 28642387
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cells. Texas Medical Board approves rules for controversial treatment.
    Kaiser J
    Science; 2012 Apr; 336(6079):284. PubMed ID: 22517830
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advanced therapy medicinal products : Scientific, medical, economic, and ethical aspects].
    Seitz R; Schneider CK; Hengel H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):789-90. PubMed ID: 21698529
    [No Abstract]   [Full Text] [Related]  

  • 4. Texas stem cell rules may impede clinical research.
    Arnold C
    Lancet; 2012 May; 379(9828):1776. PubMed ID: 22586718
    [No Abstract]   [Full Text] [Related]  

  • 5. Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.
    Bauer G; Elsallab M; Abou-El-Enein M
    Stem Cells Transl Med; 2018 Sep; 7(9):676-685. PubMed ID: 30063299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Texas H.B. 810: Increased Access to Stem Cell Interventions or an Increase in Unproven Treatments?
    Matthews K; Kunisetty B; Sprung K
    Stem Cells Dev; 2018 Nov; 27(21):1463-1465. PubMed ID: 30122128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical innovation versus stem cell tourism.
    Lindvall O; Hyun I
    Science; 2009 Jun; 324(5935):1664-5. PubMed ID: 19556497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Need for Beneficence and Prudence in Clinical Innovation with Autologous Stem Cells.
    Lipworth W; Stewart C; Kerridge I
    Perspect Biol Med; 2018; 61(1):90-105. PubMed ID: 29805150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving oversight of innovative medical interventions in Texas, USA.
    Levine AD
    Regen Med; 2012 Jul; 7(4):451-3. PubMed ID: 22817618
    [No Abstract]   [Full Text] [Related]  

  • 10. Unproven stem cell therapies: is it my right to try?
    Riva L; Campanozzi L; Vitali M; Ricci G; Tambone V
    Ann Ist Super Sanita; 2019; 55(2):179-185. PubMed ID: 31264641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hope vs. caution: ethical and regulatory considerations for neonatal stem cell therapies.
    Laventhal NT; Rivkees SA; Opipari VP
    Pediatr Res; 2018 Mar; 83(3):557-558. PubMed ID: 29244801
    [No Abstract]   [Full Text] [Related]  

  • 12. Compassionate use of experimental therapies: who should decide?
    Zettler PJ
    EMBO Mol Med; 2015 Oct; 7(10):1248-50. PubMed ID: 26202382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ethics and therapeutic innovation].
    Laugel V; Herson A; Michon CC; Malaterre JF; Segovia-Kueny S
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():46-50. PubMed ID: 30943164
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on ethics of experimental therapies.
    Michejda M
    Fetal Diagn Ther; 2004; 19(2):111-2. PubMed ID: 14764951
    [No Abstract]   [Full Text] [Related]  

  • 15. The darker side of stem cells.
    Nature; 2012 Feb; 483(7387):5. PubMed ID: 22382939
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and professional ethics guidelines for the practice of thyroidology.
    Rosenthal MS; Angelos P; Cooper DS; Fassler C; Finder SG; Hays MT; Tendler B; Braunstein GD;
    Thyroid; 2013 Oct; 23(10):1203-10. PubMed ID: 23750916
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem-cell therapy takes off in Texas.
    Cyranoski D
    Nature; 2012 Feb; 483(7387):13-4. PubMed ID: 22382952
    [No Abstract]   [Full Text] [Related]  

  • 18. Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward.
    Tiwari SS; Desai PN
    Cell Stem Cell; 2018 Nov; 23(5):649-652. PubMed ID: 30344101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory loophole enables unproven autologous cell therapies to thrive in Australia.
    Munsie M; Pera M
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():34-8. PubMed ID: 25457959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Law, ethics, and emotion: the Charlie Gard case.
    Dyer C
    BMJ; 2017 Jul; 358():j3152. PubMed ID: 28676496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.